Literature DB >> 12873279

Serotonin syndrome and other serotonergic disorders.

Rasih Atilla Ener1, Sharon B Meglathery, William A Van Decker, Rollin M Gallagher.   

Abstract

Serotonin syndrome is an iatrogenic disorder induced by pharmacologic treatment with serotonergic agents that increases serotonin activity. In addition, there is a wide variety of clinical disorders associated with serotonin excess. The frequent concurrent use of serotonergic and neuroleptic drugs and similarities between serotonin syndrome and neuroleptic malignant syndrome can present the clinician with a diagnostic challenge. In this article, we review the pathophysiology, diagnosis, and treatment of serotonin syndrome as well as other serotonergic disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873279     DOI: 10.1046/j.1526-4637.2003.03005.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  22 in total

Review 1.  Prescribed drugs and neurological complications.

Authors:  K A Grosset; D G Grosset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

2.  [The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide].

Authors:  S Cassens; E A Nickel; M Quintel; P Neumann
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

Review 3.  Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

Authors:  G Talarico; G Tosto; S Pietracupa; E Piacentini; M Canevelli; G L Lenzi; G Bruno
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

4.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

5.  Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data.

Authors:  Clare Ringland; Andrea Mant; Patricia McGettigan; Philip Mitchell; Christopher Kelman; Nicholas Buckley; Sallie-Anne Pearson
Journal:  Br J Clin Pharmacol       Date:  2008-07-08       Impact factor: 4.335

6.  Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort.

Authors:  Kara L Jablonski; Maria D Devore; Margaret A Ryan; Emily L Streeter; Jerlyn C Tolentino; Angelica A Klinski; Nahed Bahlawan
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-03

7.  [Age 89 years, depression, fall with pelvic fracture, severe confusion - serotonin syndrome : Differential diagnosis, importance of CYP450 and economic considerations].

Authors:  W Weinrebe; A Moutaouakil; K Risz; M Martin; K Jeckelmann; S Goetz
Journal:  Z Gerontol Geriatr       Date:  2017-04-18       Impact factor: 1.281

Review 8.  Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors:  J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2010-11-04       Impact factor: 2.007

9.  Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Authors:  Z Speiser; T Fine; L Litinetsky; S Eliash; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

Review 10.  A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.

Authors:  Fabrizio Schifano
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.